Effects of collagen crosslinking on porcine and human tarsal plate

BMC Ophthalmol. 2019 Dec 16;19(1):255. doi: 10.1186/s12886-019-1254-3.

Abstract

Background: Floppy eyelid syndrome is a disorder in which the tarsal plate is easily distensible and is currently treated with conservative or surgical measures. Human tarsal plate contains type I collagen, which is crosslinked in corneal tissue as a treatment for keratoconus. We hypothesized that collagen crosslinking would similarly stiffen tarsal plate tissue and investigated this in porcine and human tarsal plate specimens.

Methods: Riboflavin-sensitized porcine and human tarsus samples were irradiated with ultraviolet-A light. Porcine experiments were analyzed with gross photographs, anterior segment optical computed tomography (AS-OCT) imaging, and tensile testing. A prospective study of human tarsus was performed on samples from patients undergoing wedge resection for floppy eyelid syndrome and was analyzed with AS-OCT and tensile testing.

Results: 73 porcine adnexa and 9 patients (16 eyelids) who underwent wedge excision were included in the study. Grossly, greater stiffness was observed in crosslinked porcine tissue. AS-OCT imaging in porcine tissue showed a distinct hyperreflective band in crosslinked specimens whose area and intensity increased with longer treatment time (P = 0.003); this band was also visible in crosslinked human specimens. Tensile testing was performed, but results were not statistically significant.

Conclusions: AS-OCT imaging, which has not been previously described for tarsal plate, showed a characteristic change in crosslinked porcine and human specimens. Tissue stiffness was increased grossly, but changes in tensile properties were not statistically significant. Further study is warranted to determine relevance as a potential treatment for floppy eyelid syndrome.

Keywords: Crosslinking; Floppy eyelid syndrome; Riboflavin.

MeSH terms

  • Adult
  • Animals
  • Collagen Type I / metabolism*
  • Cross-Linking Reagents*
  • Eyelid Diseases / diagnostic imaging
  • Eyelid Diseases / drug therapy*
  • Eyelid Diseases / metabolism
  • Eyelids / diagnostic imaging
  • Eyelids / metabolism*
  • Humans
  • Photosensitizing Agents / therapeutic use*
  • Prospective Studies
  • Riboflavin / therapeutic use*
  • Swine
  • Tensile Strength
  • Tomography, Optical Coherence
  • Ultraviolet Rays

Substances

  • Collagen Type I
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Riboflavin